Literature DB >> 32698142

Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma.

Douglas Wiseman1, James D McDonald1, Dhaval Patel1, Electron Kebebew2, Karel Pacak3, Naris Nilubol1.   

Abstract

Postoperative hypotension frequently occurs after resection of pheochromocytoma and/or paraganglioma (PPGLs). Epidural anesthesia (EA) is often used for pain control in open resection of these tumors; one of its side effects is hypotension. Our aim is to determine if EA is associated with an increased risk of postoperative hypotension after open resection of PPGLs. We conducted a retrospective review of patients who underwent open resection of PPGLs at the National Institutes of Health from 2004 to 2019. Clinical and perioperative parameters were analyzed by the use of EA. The primary endpoint was postoperative hypotension. Ninety-seven patients (46 female and 51 male; mean age, 38.5 years) underwent open resection of PPGLs and 69 (71.1%) received EA. Patients with EA had a higher rate beta-blocker use (79.7% vs 57.1%, P = 0.041), metastasis (69.6% vs 39.3%, P = 0.011), and were more frequently hypotensive after surgery (58.8% vs 25.0%, P = 0.003) compared to those without EA. Patients with postoperative hypotension had higher plasma normetanephrines than those without (7.3 fold vs 4.1 fold above the upper limit of normal, P = 0.018). Independent factors associated with postoperative hypotension include the use of beta-blockers (HR = 3.35 (95% CI: 1.16-9.67), P = 0.026) and EA (HR = 3.49 (95% CI: 1.25-9.76), P = 0.017). Data from this retrospective study suggest that, in patients with open resection of PPGLs, EA is an independent risk factor for early postoperative hypotension. Special caution is required in patients on beta-blockade. A prospective evaluation with standardized protocols for the use of EA and management of hemodynamic variability is necessary.

Entities:  

Keywords:  SDHB; epidurals; paraganglioma; pheochromocytoma

Year:  2020        PMID: 32698142      PMCID: PMC7482424          DOI: 10.1530/ERC-20-0139

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  20 in total

1.  A regression model for identifying patients at high risk of hypotension, bradycardia and nausea during spinal anesthesia.

Authors:  P Tarkkila; J Isola
Journal:  Acta Anaesthesiol Scand       Date:  1992-08       Impact factor: 2.105

Review 2.  Contemporary use of β-blockers: clinical relevance of subclassification.

Authors:  Luc Poirier; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2013-12-04       Impact factor: 5.223

3.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979.

Authors:  C M Beard; S G Sheps; L T Kurland; J A Carney; J T Lie
Journal:  Mayo Clin Proc       Date:  1983-12       Impact factor: 7.616

4.  Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection.

Authors:  Toby N Weingarten; Tasha L Welch; Tamara L Moore; Gulshat F Walters; Joni L Whipple; Alexandre Cavalcante; Irina Bancos; William F Young; Lucinda M Gruber; Muhammad Z Shah; Travis J McKenzie; Darrell R Schroeder; Juraj Sprung
Journal:  Urology       Date:  2016-10-18       Impact factor: 2.649

Review 5.  Preoperative management of the pheochromocytoma patient.

Authors:  Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2007-11       Impact factor: 5.958

Review 6.  beta-Blockers in hypertension: is carvedilol different?

Authors:  Franz H Messerli; Ehud Grossman
Journal:  Am J Cardiol       Date:  2004-05-06       Impact factor: 2.778

7.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

Review 8.  Use of carvedilol in hypertension: an update.

Authors:  Gastone Leonetti; Colin G Egan
Journal:  Vasc Health Risk Manag       Date:  2012-05-18

Review 9.  A Review of Nebivolol Pharmacology and Clinical Evidence.

Authors:  Justin Fongemie; Erika Felix-Getzik
Journal:  Drugs       Date:  2015-08       Impact factor: 9.546

10.  Combined epidural-general anesthesia was associated with lower risk of postoperative complications in patients undergoing open abdominal surgery for pheochromocytoma: A retrospective cohort study.

Authors:  Nan Li; Hao Kong; Shuang-Ling Li; Sai-Nan Zhu; Dong-Xin Wang
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

View more
  3 in total

1.  Long-term sexual dysfunction and hypotensive shock in a patient with a pheochromocytoma.

Authors:  Haotian Chen; Ziwei Zhang; Wentao Zhang; Fuhan Yang; Shiyu Mao; Yuan Wu; Junfeng Zhang; Yang Yan; Xudong Yao
Journal:  Int Urol Nephrol       Date:  2022-04-06       Impact factor: 2.370

Review 2.  Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment.

Authors:  Sara Talvacchio; Matthew A Nazari; Karel Pacak
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

Review 3.  Anesthesia in Children with Neuroblastoma, Perioperative and Operative Management.

Authors:  Costanza Tognon; Rebecca Pulvirenti; Federica Fati; Federica De Corti; Elisabetta Viscardi; Andrea Volpe; Piergiorgio Gamba
Journal:  Children (Basel)       Date:  2021-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.